See the DrugPatentWatch profile for Steglatro
What is Steglatro?
Steglatro is a prescription medication used to improve blood sugar control in adults with type 2 diabetes [1]. It is taken orally once a day and is available as a tablet [1].
How does Steglatro work?
Steglatro belongs to a class of drugs called SGLT2 inhibitors [1]. It works by blocking the reabsorption of glucose in the kidneys, which causes excess glucose to be removed from the body through urine [1]. This mechanism helps to lower blood sugar levels [1].
When did Steglatro become available?
Steglatro received FDA approval in December 2019 [2].
Who makes Steglatro?
Steglatro is manufactured by Pfizer [1].
What is the patent status for Steglatro?
Patent information for Steglatro can be found on DrugPatentWatch.com [3]. DrugPatentWatch provides details on patent expiry dates, exclusivity periods, and any ongoing patent litigation that could affect the drug's market exclusivity [3].
What are the common side effects of Steglatro?
Common side effects reported with Steglatro include yeast infections of the vagina and penis, urinary tract infections, and increased urination [1]. It is important to discuss any potential side effects with a healthcare provider [1].
What are the risks associated with Steglatro?
Steglatro carries a risk of certain serious side effects, including diabetic ketoacidosis, particularly in individuals with type 1 diabetes or those on higher insulin doses [1]. It can also lead to serious urinary tract infections and Fournier's gangrene, a rare but serious infection of the tissue between the anus and the scrotum [1]. Furthermore, Steglatro may cause dehydration and a drop in blood pressure, especially in older adults or those taking diuretics [1].
How does Steglatro compare to other diabetes medications?
As an SGLT2 inhibitor, Steglatro functions differently from other classes of diabetes medications like metformin or DPP-4 inhibitors [1]. Its effectiveness and side effect profile may vary compared to these other drug classes [1]. Decisions about medication choice are typically made based on individual patient needs and medical history [1].
Are there alternative treatments for type 2 diabetes?
Yes, a range of treatment options exist for type 2 diabetes, including lifestyle modifications such as diet and exercise, as well as other classes of oral medications and injectable therapies [1]. The most suitable treatment plan is determined by a healthcare professional [1].
---
Sources:
[1] https://www.steglatro.com/
[2] https://www.drugs.com/newdrugs/steglatro-ertugliflozin-approved-treat-type-2-diabetes-5383.html
[3] https://www.drugpatentwatch.com/